These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23094394)

  • 1. [European guidelines for lipid treatment are tailored according to risk level].
    Wiklund O
    Lakartidningen; 2012 Sep 19-26; 109(38):1653. PubMed ID: 23094394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mediterranean diet and statins against cardiovascular disease].
    Håkansson J
    Lakartidningen; 2012 Sep 5-11; 109(36):1540-3. PubMed ID: 23016236
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 4. Worth the wait? A new paradigm for treating cholesterol to reduce cardiovascular risk.
    Messerschmidt K
    S D Med; 2014 Feb; 67(2):70-1. PubMed ID: 24624603
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe.
    Thompson GR; Catapano A; Saheb S; Atassi-Dumont M; Barbir M; Eriksson M; Paulweber B; Sijbrands E; Stalenhoef AF; Parhofer KG
    Curr Opin Lipidol; 2010 Dec; 21(6):492-8. PubMed ID: 20935563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Government cholesterol recommendations questioned.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Oct; 15(20):9-10, 12. PubMed ID: 15505935
    [No Abstract]   [Full Text] [Related]  

  • 7. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart health and diet.
    Colt E
    J Am Diet Assoc; 2008 Jan; 108(1):34. PubMed ID: 18155985
    [No Abstract]   [Full Text] [Related]  

  • 10. An update to the National Cholesterol Education Program: 2009 suggested changes.
    Medina-Ruíz A
    Bol Asoc Med P R; 2009; 101(4):30-3. PubMed ID: 20853557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paradigm shift with the new American guidelines for lipid-lowering therapy].
    Hjemdahl P; Andersén-Karlsson E
    Lakartidningen; 2014 Apr 2-8; 111(14):596-7. PubMed ID: 24779174
    [No Abstract]   [Full Text] [Related]  

  • 12. [2016 European Society of Cardiology guidelines for the management of dyslipidemias].
    Ferrières J
    Presse Med; 2017; 46(7-8 Pt 1):688-696. PubMed ID: 28502376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
    Olsson AG
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterpoint: Low-density lipoprotein cholesterol goals in patients with diabetes are adequately based on evidence.
    Davidson MH
    J Clin Lipidol; 2010; 4(1):72-3; discussion 74. PubMed ID: 21122630
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidence.
    Gosmanov AR
    J Clin Lipidol; 2010; 4(1):69-71; discussion 74. PubMed ID: 21122629
    [No Abstract]   [Full Text] [Related]  

  • 17. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 18. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
    Mason CM
    Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol goals established for patients with diabetes and metabolic syndrome.
    Haffner SM
    Am J Manag Care; 2002 Jan; Suppl():6-7. PubMed ID: 11833456
    [No Abstract]   [Full Text] [Related]  

  • 20. Don't trust an LDL over 70?
    Aronow WS
    Geriatrics; 2004 May; 59(5):12-3. PubMed ID: 15152729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.